Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas F Patterson

Showing results (181-190 of 204) with videos related to

Pageof 21
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 22, 2008
Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteriaBrahm H Segal, Raoul Herbrecht, David A Stevens, et al.
Intensive Care Medicine|June 24, 2020
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinionPaul E Verweij, Bart J A Rijnders, Roger J M Brüggemann, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 9, 2008
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus GroupBen De Pauw, Thomas J Walsh, J Peter Donnelly, et al.
Nature|November 8, 2023
Tuning sterol extraction kinetics yields a renal-sparing polyene antifungalArun Maji, Corinne P Soutar, Jiabao Zhang, et al.
The New England Journal of Medicine|May 24, 2020
Remdesivir for the Treatment of Covid-19 - Final ReportJohn H Beigel, Kay M Tomashek, Lori E Dodd, et al.
Medrxiv : the Preprint Server for Health Sciences|September 29, 2022
Infliximab for Treatment of Adults Hospitalized with Moderate or Severe Covid-19Jane A O'Halloran, Eyal Kedar, Kevin J Anstrom, et al.
The Lancet. Infectious Diseases|February 19, 2021
Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for MicrobiologyMartin Hoenigl, Jon Salmanton-García, Thomas J Walsh, et al.
JAMA Neurology|November 10, 2025
Evaluation of Interventions for Cognitive Symptoms in Long COVID: A Randomized Clinical TrialDavid S Knopman, Deborah Koltai, Daniel T Laskowitz, et al.
Journal of the American Geriatrics Society|September 1, 2025
Age-Related Changes in the Clinical Picture of Long COVIDMindy J Fain, Benjamin D Horne, Leora I Horwitz, et al.
Medrxiv : the Preprint Server for Health Sciences|October 7, 2022
Abatacept for Treatment of Adults Hospitalized with Moderate or Severe Covid-19Emily R Ko, Kevin J Anstrom, Reynold A Panettieri, et al.
Pageof 21

Showing results (181-190 of 204) with videos related to

Sort By:
Pageof 21
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 22, 2008
Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteriaBrahm H Segal, Raoul Herbrecht, David A Stevens, et al.
Intensive Care Medicine|June 24, 2020
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinionPaul E Verweij, Bart J A Rijnders, Roger J M Brüggemann, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 9, 2008
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus GroupBen De Pauw, Thomas J Walsh, J Peter Donnelly, et al.
Nature|November 8, 2023
Tuning sterol extraction kinetics yields a renal-sparing polyene antifungalArun Maji, Corinne P Soutar, Jiabao Zhang, et al.
The New England Journal of Medicine|May 24, 2020
Remdesivir for the Treatment of Covid-19 - Final ReportJohn H Beigel, Kay M Tomashek, Lori E Dodd, et al.
Medrxiv : the Preprint Server for Health Sciences|September 29, 2022
Infliximab for Treatment of Adults Hospitalized with Moderate or Severe Covid-19Jane A O'Halloran, Eyal Kedar, Kevin J Anstrom, et al.
The Lancet. Infectious Diseases|February 19, 2021
Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for MicrobiologyMartin Hoenigl, Jon Salmanton-García, Thomas J Walsh, et al.
JAMA Neurology|November 10, 2025
Evaluation of Interventions for Cognitive Symptoms in Long COVID: A Randomized Clinical TrialDavid S Knopman, Deborah Koltai, Daniel T Laskowitz, et al.
Journal of the American Geriatrics Society|September 1, 2025
Age-Related Changes in the Clinical Picture of Long COVIDMindy J Fain, Benjamin D Horne, Leora I Horwitz, et al.
Medrxiv : the Preprint Server for Health Sciences|October 7, 2022
Abatacept for Treatment of Adults Hospitalized with Moderate or Severe Covid-19Emily R Ko, Kevin J Anstrom, Reynold A Panettieri, et al.
Pageof 21